CUSIP: 74365A101
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,424,970
-
Share change
-
-11,067,806
-
Total reported value
-
$11,449,400
-
Put/Call ratio
-
177%
-
Price per share
-
$1.36
-
Number of holders
-
25
-
Value change
-
-$5,168,348
-
Number of buys
-
15
-
Number of sells
-
17
Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q1 2017
As of 31 Mar 2017,
PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,424,970 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, RENAISSANCE TECHNOLOGIES LLC, Ion Asset Management Ltd., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, DEUTSCHE BANK AG\, BRIDGEWAY CAPITAL MANAGEMENT INC, A.R.T. Advisors, LLC, JANE STREET GROUP, LLC, SIMPLEX TRADING, LLC, and WOLVERINE ASSET MANAGEMENT LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.